VP at Acadia Pharmaceuticals, pled guilty to insider trading, avoiding a $1.3M loss by illicitly selling shares ahead of a ...

Demos, a medical doctor who was the Vice President of Drug Safety and Pharmacovigilance and member of the drug label team at ...

A former pharmaceutical executive traded on nonpublic information about an antipsychotic drug’s development, avoiding $1.3 ...

George Demos admitted selling more than 60,000 company shares just before news broke regarding an issue with one of the ...

The former vice president of a Carmel Valley pharmaceutical company pleaded guilty Friday to a federal securities fraud count.

George Demos, 64, of San Diego, knew about negative news that involved the labeling process for a prescription drug with the Food and Drug Administration, Kelly Thornton with the United States ...

George Demos, 64, formerly of Acadia Pharmaceuticals Inc., admitted selling more than 60,000 company shares just before news broke regarding an issue with one of the company's products ...

George Demos, 64, of San Diego, knew about negative news that involved the labeling process for a prescription drug with the Food and Drug Administration, Kelly Thornton with the United States ...